"...Assuming we see TB results by Sept 30 – and that those are...

"...Assuming we see TB results by Sept 30 – and that those are unambiguously positive – it would be newsworthy – and in a general sense..." Indeed, Fela.

But here's the thing: If the TB results are positive how can we ascribe a value to $PO3? First indication will be the size of movement in market cap. But any updraft could soon be subsumed by other events.

Right now, neither PO3 nor its "joined-at-the-hip" affiliate Somnio Global have the infrastructure for a launch of the FRG weapon against TB in India and beyond.

They will need help, presumably from a US-based OEM with deep reach into the Indian medical system.

They will need to address regulatory hurdles. And, of course, they'll need to address the money hurdle.

The stretched/stressed Indian medical system would need to apply triaging filters, asking questions such as: Do we divert money to buy/instal FRGs for TB and mold? How much can we spend? When?

Clearly, with TB - as is the case with virtually everything PuriflOH's doing - we and the market will need to maintain abiding patience.